Own report: The whole country is terrified. If someone has heart, liver and kidney problems or diabetes, then there is no question. The worries of the family are increasing several times. The Council of Scientific and Industrial Research (CSIR) sheds light on this darkness of panic.

The company soon began testing a drug for patients with COMBD, they said. So the drug controller agreed. The drug that the Council of Scientific and Industrial Research (CSIR) has begun experimental use with is called colchicine. However, this is not a new drug. It is being tested experimentally on heart patients with covid infections.

Read more: Huge amounts of vaccines fall into private hospitals, with only 2.2 million given last month

Read more: Do not panic about increasing the interval between two doses of CovishieldCenter

The experimental application has been started at CSIR’s Indian Institute of Chemical Technology Lab and Life Science Pvt. Ltd., Hyderabad. Kolacisin may be effective for patients with coronary artery disease, said CS Mande, director general of CSIR.

(Zee 24 Ghanta AppDownload Zee 24 Ghanta App to read latest news on Country, World, State, Kolkata, Entertainment, Sports, Lifestyle, Health, Technology)